Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01744054 · ClinicalTrials.gov registry record · Phase 1
Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization
A Phase 1 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Phase 1
- Development phase
- 57
- Enrollment target
NCT01744054 is a Phase 1 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 57 participants.
The verdict
NCT01744054, a Phase 1 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 57 participants
- Enrollment target
Study Summary
The successful localization of the y90 microspheres by PET/MR and/or PET/CT scans would be a useful tool in individualizing patient care after the radioembolization procedure. The information from a PET/MR or PET/CT scan would allow for early evaluation of the technical success of the procedure.
Interventions
- DEVICE PET/MR
- DEVICE PET/CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2012-10-25 |
| Est. Completion | 2017-04-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01744054
The ClinicalTrials.gov registry entry for NCT01744054 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PET/MR is the first listed.
NCT01744054 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01744054 about?
NCT01744054 is a clinical study titled "Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization". The successful localization of the y90 microspheres by PET/MR and/or PET/CT scans would be a useful tool in individualizing patient care after the radioembolization procedure. The information from a PET/MR or PET/CT scan would allow for early evaluation of the technical success of the procedure.
What is the current status of trial NCT01744054?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 57 participants. The study started on 2012-10-25. Estimated completion is 2017-04-03.
What interventions are being tested in trial NCT01744054?
The interventions under investigation include: PET/MR (DEVICE), PET/CT (DEVICE).
Who is sponsoring clinical trial NCT01744054?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.